Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $65.9 Million - $83.4 Million
-613,285 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $7.01 Million - $7.95 Million
-65,860 Reduced 9.7%
613,285 $66.2 Million
Q2 2021

Aug 16, 2021

SELL
$105.21 - $117.21 $7.94 Million - $8.84 Million
-75,444 Reduced 10.0%
679,145 $76.5 Million
Q1 2021

May 17, 2021

SELL
$102.3 - $112.62 $711,291 - $783,046
-6,953 Reduced 0.91%
754,589 $81.6 Million
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $214,666 - $289,822
2,667 Added 0.35%
761,542 $80.2 Million
Q3 2020

Nov 12, 2020

SELL
$85.91 - $100.83 $1.22 Million - $1.43 Million
-14,159 Reduced 1.83%
758,875 $65.9 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $3.49 Million - $4.67 Million
47,597 Added 6.56%
773,034 $74.6 Million
Q1 2020

May 13, 2020

BUY
$64.5 - $97.79 $1.99 Million - $3.01 Million
30,797 Added 4.43%
725,437 $54.6 Million
Q4 2019

Feb 13, 2020

BUY
$72.13 - $90.25 $4.62 Million - $5.77 Million
63,987 Added 10.15%
694,640 $61.5 Million
Q3 2019

Nov 13, 2019

SELL
$62.98 - $75.72 $4.6 Million - $5.53 Million
-73,088 Reduced 10.39%
630,653 $47.2 Million
Q2 2019

Aug 14, 2019

SELL
$65.7 - $83.98 $4.79 Million - $6.12 Million
-72,895 Reduced 9.39%
703,741 $49.3 Million
Q1 2019

May 15, 2019

BUY
$77.14 - $90.79 $1.16 Million - $1.37 Million
15,076 Added 1.98%
776,636 $62.1 Million
Q4 2018

Feb 13, 2019

SELL
$77.85 - $96.01 $3.22 Million - $3.97 Million
-41,356 Reduced 5.15%
761,560 $69.4 Million
Q3 2018

Nov 13, 2018

SELL
$88.91 - $98.84 $5.07 Million - $5.64 Million
-57,013 Reduced 6.63%
802,916 $75.6 Million
Q2 2018

Aug 13, 2018

BUY
$89.78 - $106.23 $3.82 Million - $4.52 Million
42,592 Added 5.21%
859,929 $79.7 Million
Q1 2018

May 15, 2018

BUY
$92.01 - $123.21 $9.8 Million - $13.1 Million
106,547 Added 14.99%
817,337 $77.1 Million
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $1.98 Million - $2.17 Million
-22,102 Reduced 3.02%
710,790 $68.7 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $4.97 Million - $6.34 Million
71,093 Added 10.74%
732,892 $65.1 Million
Q2 2017

Aug 14, 2017

BUY
N/A
661,799
661,799 $48 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Amp Capital Investors LTD Portfolio

Follow Amp Capital Investors LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amp Capital Investors LTD, based on Form 13F filings with the SEC.

News

Stay updated on Amp Capital Investors LTD with notifications on news.